GoHealth, Inc. Class A Common Stock
Here’s whether GoHealth, Inc. Class A Common Stock (GOCO) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.
Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-19.30% over 10 days); RSI 27 — oversold; weak 1-year return of -95.0%; 3-month momentum negative (-82.4%); rising volume on a downtrend (distribution, 2.55x avg). Currently 95.9% off its 52-week high. Score: -7/7.
GOCO is trading below its 200-day MA ($2.48) — a key warning sign the longer-term trend is under pressure. An RSI of 26.6 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of -95.0% compares to +22.9% for SPY (trailed the market by 117.9%). The current 95.9% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.